Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular Degenerationgene therapyage-related macular degenerationAAVInhibition of vascular endothelial growth factor, a key contributor to the choroidal neovascularization associated with wet age-related macular ...
Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular Degeneration.doi:10.1016/j.ymthe.2018.11.003Ruslan GrishaninBrian VuillemenotPallavi SharmaAnnahita KeravalaJudith GreengardClaire GelfmanMark Blumenkrantz...